BillionToOne Insider Trades
NASDAQ: BLLNHealth CareMedical SpecialitiesUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Last 12 months
- Purchases
- 0 · $0
- Sales
- 57 · $21.07M
- Shares bought / sold
- 0 / 192.54K
- Net activity
- Net selling $21.1 million
BillionToOne insider activity
Over the last 12 months, BillionToOne insiders reported 100 transactions on SEC Form 4: 0 open-market purchases and 57 sales. Insiders bought $0 and sold $21.1 million worth of stock, for net insider selling of $21.1 million. The largest seller was Atay Oguzhan, with $7.7 million in reported sales.
The most recent filing shows Tsao David (Chief Technology Officer) reporting a transaction in 10,000 shares at $2.80 on Oct 5, 2026. Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put BLLN's ownership changes in context.
Summary generated from market data by MetaCap's automated system. Methodology
BLLN insider transactions
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| Oct 5, 2026 | ten Bosch John RoderickSVP of Laboratory Operations | Sale | 1,417 | $149.00K | Form 4 |
| Oct 5, 2026 | ten Bosch John RoderickSVP of Laboratory Operations | Sale | 1,417 | $149.00K | Form 4 |
| Oct 5, 2026 | Tsao DavidChief Technology Officer | Sale | 100 | $11.01K | Form 4 |
| Oct 5, 2026 | Tsao DavidChief Technology Officer | Sale | 1,829 | $199.63K | Form 4 |
| Oct 5, 2026 | Tsao DavidChief Technology Officer | Sale | 4,916 | $533.55K | Form 4 |
| Oct 5, 2026 | Tsao DavidChief Technology Officer | Sale | 2,200 | $236.44K | Form 4 |
| Oct 5, 2026 | Tsao DavidChief Technology Officer | Sale | 400 | $42.44K | Form 4 |
| Oct 5, 2026 | Tsao DavidChief Technology Officer | Sale | 555 | $58.59K | Form 4 |
| Oct 5, 2026 | Tsao DavidChief Technology Officer | Sale | 20 | $2.20K | Form 4 |
| Oct 5, 2026 | Tsao DavidChief Technology Officer | Sale | 2,921 | $318.40K | Form 4 |
| Oct 5, 2026 | Tsao DavidChief Technology Officer | Sale | 4,284 | $464.36K | Form 4 |
| Oct 5, 2026 | Tsao DavidChief Technology Officer | Sale | 1,909 | $204.64K | Form 4 |
| Oct 5, 2026 | Tsao DavidChief Technology Officer | Sale | 866 | $91.71K | Form 4 |
| Oct 5, 2026 | Tsao DavidChief Technology Officer | Option exercise | 10,000 | $28.00K | Form 4 |
| Oct 5, 2026 | Tsao DavidChief Technology Officer | Option exercise | 10,000 | $28.00K | Form 4 |
| Sep 28, 2026 | Atay OguzhanChairman and CEO | Sale | 2,666 | $321.63K | Form 4 |
| Sep 28, 2026 | Atay OguzhanChairman and CEO | Sale | 8,333 | $1.01M | Form 4 |
| Sep 28, 2026 | Atay OguzhanChairman and CEO | Option exercise | 8,333 | $23.33K | Form 4 |
| Sep 24, 2026 | ten Bosch John RoderickSVP of Laboratory Operations | Sale | 1,416 | $169.92K | Form 4 |
| Sep 24, 2026 | Tsao DavidChief Technology Officer | Sale | 3,333 | $416.63K | Form 4 |
| Sep 24, 2026 | Tsao DavidChief Technology Officer | Option exercise | 3,333 | $9.33K | Form 4 |
| Sep 21, 2026 | ten Bosch John RoderickSVP of Laboratory Operations | Sale | 1,416 | $150.96K | Form 4 |
| Sep 17, 2026 | Lynch Thomas P.See Remarks | Sale | 5,840 | $644.11K | Form 4 |
| Sep 17, 2026 | Lynch Thomas P.See Remarks | Sale | 2,920 | $322.10K | Form 4 |
| Sep 17, 2026 | Lynch Thomas P.See Remarks | Sale | 6,968 | $768.56K | Form 4 |
| Sep 17, 2026 | Lynch Thomas P.See Remarks | Sale | 19,384 | $2.14M | Form 4 |
| Sep 17, 2026 | Lynch Thomas P.See Remarks | Option exercise | 5,840 | $179.76K | Form 4 |
| Sep 17, 2026 | Lynch Thomas P.See Remarks | Option exercise | 2,920 | $49.99K | Form 4 |
| Sep 17, 2026 | Lynch Thomas P.See Remarks | Option exercise | 6,968 | $80.48K | Form 4 |
| Sep 17, 2026 | Lynch Thomas P.See Remarks | Option exercise | 19,384 | $167.67K | Form 4 |
| Sep 14, 2026 | Atay OguzhanChairman and CEO | Sale | 2,666 | $261.27K | Form 4 |
| Sep 14, 2026 | Atay OguzhanChairman and CEO | Sale | 2,666 | $261.27K | Form 4 |
| Sep 14, 2026 | Atay OguzhanChairman and CEO | Sale | 3,143 | $318.99K | Form 4 |
| Sep 14, 2026 | Atay OguzhanChairman and CEO | Sale | 2,010 | $202.56K | Form 4 |
| Sep 14, 2026 | Atay OguzhanChairman and CEO | Sale | 1,500 | $149.35K | Form 4 |
| Sep 14, 2026 | Atay OguzhanChairman and CEO | Sale | 1,680 | $165.71K | Form 4 |
| Sep 14, 2026 | Atay OguzhanChairman and CEO | Sale | 7,214 | $731.79K | Form 4 |
| Sep 14, 2026 | Atay OguzhanChairman and CEO | Sale | 2,531 | $254.57K | Form 4 |
| Sep 14, 2026 | Atay OguzhanChairman and CEO | Sale | 2,456 | $244.55K | Form 4 |
| Sep 14, 2026 | Atay OguzhanChairman and CEO | Sale | 4,465 | $440.39K | Form 4 |
| Sep 14, 2026 | Atay OguzhanChairman and CEO | Option exercise | 8,333 | $23.33K | Form 4 |
| Sep 14, 2026 | Atay OguzhanChairman and CEO | Option exercise | 16,666 | $46.66K | Form 4 |
| Sep 10, 2026 | Sakakibara Shan RikuChief Product Officer | Gift | 3,500 | — | Form 4 |
| Sep 9, 2026 | Atay OguzhanChairman and CEO | Gift | 20,000 | — | Form 4 |
| Sep 9, 2026 | Tsao DavidChief Technology Officer | Sale | 10,000 | $1.00M | Form 4 |
| Sep 9, 2026 | Tsao DavidChief Technology Officer | Sale | 10,000 | $975.40K | Form 4 |
| Sep 9, 2026 | Tsao DavidChief Technology Officer | Option exercise | 10,000 | $28.00K | Form 4 |
| Sep 9, 2026 | Tsao DavidChief Technology Officer | Option exercise | 10,000 | $28.00K | Form 4 |
| Sep 9, 2026 | ten Bosch John RoderickSVP of Laboratory Operations | Sale | 1,416 | $138.12K | Form 4 |
| Sep 8, 2026 | Tsao DavidChief Technology Officer | Gift | 20,000 | — | Form 4 |
| Sep 8, 2026 | Atay OguzhanChairman and CEO | Conversion | 20,000 | — | Form 4 |
| Sep 8, 2026 | Lynch Thomas P.See Remarks | Sale | 232 | $23.41K | Form 4 |
| Sep 8, 2026 | Lynch Thomas P.See Remarks | Sale | 2,518 | $252.29K | Form 4 |
| Sep 8, 2026 | Lynch Thomas P.See Remarks | Sale | 576 | $56.96K | Form 4 |
| Sep 8, 2026 | Lynch Thomas P.See Remarks | Sale | 147 | $14.91K | Form 4 |
| Sep 8, 2026 | Lynch Thomas P.See Remarks | Sale | 1,131 | $113.47K | Form 4 |
| Sep 8, 2026 | Lynch Thomas P.See Remarks | Sale | 385 | $38.20K | Form 4 |
| Sep 8, 2026 | Lynch Thomas P.See Remarks | Sale | 358 | $36.09K | Form 4 |
| Sep 8, 2026 | Lynch Thomas P.See Remarks | Sale | 2,997 | $300.04K | Form 4 |
| Sep 8, 2026 | Lynch Thomas P.See Remarks | Sale | 614 | $60.79K | Form 4 |
| Sep 8, 2026 | Lynch Thomas P.See Remarks | Sale | 775 | $78.14K | Form 4 |
| Sep 8, 2026 | Lynch Thomas P.See Remarks | Sale | 8,285 | $829.52K | Form 4 |
| Sep 8, 2026 | Lynch Thomas P.See Remarks | Sale | 1,944 | $192.39K | Form 4 |
| Sep 8, 2026 | Lynch Thomas P.See Remarks | Sale | 38 | $3.67K | Form 4 |
| Sep 8, 2026 | Lynch Thomas P.See Remarks | Option exercise | 3,326 | $102.37K | Form 4 |
| Sep 8, 2026 | Lynch Thomas P.See Remarks | Option exercise | 1,663 | $28.47K | Form 4 |
| Sep 8, 2026 | Lynch Thomas P.See Remarks | Option exercise | 3,969 | $45.84K | Form 4 |
| Sep 8, 2026 | Lynch Thomas P.See Remarks | Option exercise | 11,042 | $95.51K | Form 4 |
| Sep 3, 2026 | Tsao DavidChief Technology Officer | Conversion | 20,000 | — | Form 4 |
| Aug 26, 2026 | KOLLURI KRISHNA KITTUDirector | other | 5,644 | — | Form 4 |
| Aug 26, 2026 | KOLLURI KRISHNA KITTUDirector | other | 15,244 | — | Form 4 |
| Aug 26, 2026 | KOLLURI KRISHNA KITTUDirector | other | 1,666 | — | Form 4 |
| Aug 26, 2026 | KOLLURI KRISHNA KITTUDirector | other | 5,761 | — | Form 4 |
| Aug 26, 2026 | KOLLURI KRISHNA KITTUDirector | other | 719 | — | Form 4 |
| Aug 26, 2026 | KOLLURI KRISHNA KITTUDirector | other | 719 | — | Form 4 |
| Aug 26, 2026 | KOLLURI KRISHNA KITTUDirector | other | 10,921 | — | Form 4 |
| Aug 26, 2026 | KOLLURI KRISHNA KITTUDirector | other | 38,106 | — | Form 4 |
| Aug 26, 2026 | KOLLURI KRISHNA KITTUDirector | other | 38,106 | — | Form 4 |
| Aug 26, 2026 | KOLLURI KRISHNA KITTUDirector | other | 271,028 | — | Form 4 |
| Aug 26, 2026 | KOLLURI KRISHNA KITTUDirector | other | 2,405 | — | Form 4 |
| Aug 26, 2026 | KOLLURI KRISHNA KITTUDirector | other | 2,405 | — | Form 4 |
| Aug 26, 2026 | KOLLURI KRISHNA KITTUDirector | other | 24,222 | — | Form 4 |
| Aug 26, 2026 | KOLLURI KRISHNA KITTUDirector | other | 7,980 | — | Form 4 |
| Aug 26, 2026 | KOLLURI KRISHNA KITTUDirector | other | 7,980 | — | Form 4 |
| Aug 26, 2026 | KOLLURI KRISHNA KITTUDirector | other | 129,780 | — | Form 4 |
| Aug 25, 2026 | ten Bosch John RoderickSVP of Laboratory Operations | Sale | 1,417 | $141.70K | Form 4 |
| Aug 25, 2026 | Tsao DavidChief Technology Officer | Sale | 10,000 | $1.00M | Form 4 |
| Aug 25, 2026 | Tsao DavidChief Technology Officer | Option exercise | 10,000 | $28.00K | Form 4 |
| Aug 10, 2026 | Tsao DavidChief Technology Officer | Sale | 10,000 | $928.60K | Form 4 |
| Aug 10, 2026 | Tsao DavidChief Technology Officer | Option exercise | 10,000 | $28.00K | Form 4 |
| Aug 10, 2026 | ten Bosch John RoderickSVP of Laboratory Operations | Sale | 1,417 | $131.58K | Form 4 |
| Aug 5, 2026 | Atay OguzhanChairman and CEO | Sale | 15,539 | $2.33M | Form 4 |
| Aug 5, 2026 | Atay OguzhanChairman and CEO | Option exercise | 15,539 | $43.51K | Form 4 |
| Aug 3, 2026 | Atay OguzhanChairman and CEO | Sale | 6,354 | $866.84K | Form 4 |
| Aug 3, 2026 | Atay OguzhanChairman and CEO | Sale | 135 | $18.28K | Form 4 |
| Aug 3, 2026 | Atay OguzhanChairman and CEO | Sale | 555 | $74.26K | Form 4 |
| Aug 3, 2026 | Atay OguzhanChairman and CEO | Sale | 269 | $35.78K | Form 4 |
| Aug 3, 2026 | Atay OguzhanChairman and CEO | Option exercise | 6,250 | $17.50K | Form 4 |
| Aug 3, 2026 | Atay OguzhanChairman and CEO | Option exercise | 6,250 | $17.50K | Form 4 |
| Aug 3, 2026 | Atay OguzhanChairman and CEO | Option exercise | 20,000 | $56.00K | Form 4 |
Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4